BACKGROUND/AIM: X linked retinoschisis (XLRS) is caused by mutations in RS1 which encodes the discoidin domain protein retinoschisin, secreted by photoreceptors and bipolar cells. Missense mutations occur throughout the gene and some of these are known to interfere with protein secretion. This study was designed to investigate the functional consequences of missense mutations at different locations in retinoschisin. METHODS AND RESULTS: The authors developed a structural model of the retinoschisin discoidin domain and used this to predict the effects of missense mutations. They expressed disease associated mutations and found that those affecting conserved residues prevented retinoschisin secretion. Most of the remaining mutations cluster within a series of loops on the surface of the beta barrel structure and do not interfere with secretion, suggesting this region may be a ligand binding site. They also demonstrated that wild type retinoschisin octamerises and associates with the cell surface. A subgroup of secreted mutations reduce oligomerisation (C59S, C219G, C223R). CONCLUSIONS: It is suggested that there are three different molecular mechanisms which lead to XLRS: mutations interfering with secretion, mutations interfering with oligomerisation, and mutations that allow secretion and oligomerisation but interfere with retinoschisin function. The authors conclude that binding of oligomerised retinoschisin at the cell surface is important in its presumed role in cell adhesion.
BACKGROUND/AIM: X linked retinoschisis (XLRS) is caused by mutations in RS1 which encodes the discoidin domain protein retinoschisin, secreted by photoreceptors and bipolar cells. Missense mutations occur throughout the gene and some of these are known to interfere with protein secretion. This study was designed to investigate the functional consequences of missense mutations at different locations in retinoschisin. METHODS AND RESULTS: The authors developed a structural model of the retinoschisin discoidin domain and used this to predict the effects of missense mutations. They expressed disease associated mutations and found that those affecting conserved residues prevented retinoschisin secretion. Most of the remaining mutations cluster within a series of loops on the surface of the beta barrel structure and do not interfere with secretion, suggesting this region may be a ligand binding site. They also demonstrated that wild type retinoschisin octamerises and associates with the cell surface. A subgroup of secreted mutations reduce oligomerisation (C59S, C219G, C223R). CONCLUSIONS: It is suggested that there are three different molecular mechanisms which lead to XLRS: mutations interfering with secretion, mutations interfering with oligomerisation, and mutations that allow secretion and oligomerisation but interfere with retinoschisin function. The authors conclude that binding of oligomerised retinoschisin at the cell surface is important in its presumed role in cell adhesion.
Authors: S Macedo-Ribeiro; W Bode; R Huber; M A Quinn-Allen; S W Kim; T L Ortel; G P Bourenkov; H D Bartunik; M T Stubbs; W H Kane; P Fuentes-Prior Journal: Nature Date: 1999-11-25 Impact factor: 49.962
Authors: Tao Wang; Caroline T Waters; Alex M K Rothman; Tracy J Jakins; Karin Römisch; Dorothy Trump Journal: Hum Mol Genet Date: 2002-11-15 Impact factor: 6.150
Authors: Bernhard H F Weber; Heinrich Schrewe; Laurie L Molday; Andrea Gehrig; Karen L White; Mathias W Seeliger; Gesine B Jaissle; Christoph Friedburg; Ernst Tamm; Robert S Molday Journal: Proc Natl Acad Sci U S A Date: 2002-04-30 Impact factor: 11.205
Authors: C Grayson; S N Reid; J A Ellis; A Rutherford; J C Sowden; J R Yates; D B Farber; D Trump Journal: Hum Mol Genet Date: 2000-07-22 Impact factor: 6.150
Authors: Seok H Min; Laurie L Molday; Mathias W Seeliger; Astra Dinculescu; Adrian M Timmers; Andreas Janssen; Felix Tonagel; Naoyuki Tanimoto; Bernhard H F Weber; Robert S Molday; William W Hauswirth Journal: Mol Ther Date: 2005-10 Impact factor: 11.454
Authors: Frank M Dyka; Winco W H Wu; Tom A Pfeifer; Laurie L Molday; Thomas A Grigliatti; Robert S Molday Journal: Biochemistry Date: 2008-08-09 Impact factor: 3.162
Authors: Catherine Cukras; Henry E Wiley; Brett G Jeffrey; H Nida Sen; Amy Turriff; Yong Zeng; Camasamudram Vijayasarathy; Dario Marangoni; Lucia Ziccardi; Sten Kjellstrom; Tae Kwon Park; Suja Hiriyanna; J Fraser Wright; Peter Colosi; Zhijian Wu; Ronald A Bush; Lisa L Wei; Paul A Sieving Journal: Mol Ther Date: 2018-07-07 Impact factor: 11.454
Authors: Jacque L Duncan; Kavitha Ratnam; David G Birch; Sanna M Sundquist; Anna S Lucero; Yuhua Zhang; Meira Meltzer; Nizar Smaoui; Austin Roorda Journal: Invest Ophthalmol Vis Sci Date: 2011-12-20 Impact factor: 4.799
Authors: J Jason McAnany; Jason C Park; Frederick T Collison; Gerald A Fishman; Edwin M Stone Journal: Doc Ophthalmol Date: 2016-07-01 Impact factor: 2.379